Newsroom

Lawmakers call for investigation of political interference at CDC

September 24, 2020

WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), the chair of the House Energy and Commerce Committee's Oversight and Investigations panel, and others sent a letter today calling for a formal U.S. Department of Health and Human Services Inspector General investigation into allegations that the White House and its appointees have interfered with the work of U.S.

House advances two key measures authored by DeGette to combat climate crisis and clean-up heavily polluted communities

September 24, 2020

Press Release

WASHINGTON, D.C. – The U.S. House of Representatives voted today to include two key amendments authored by U.S. Rep. Diana DeGette (D-CO) in a sweeping new clean-energy bill the chamber is expected to vote on this Friday.

Key House oversight panel to hear from experts on how vaccines should be evaluated for safety

September 23, 2020

Press Release

A key House oversight panel, led by U.S. Rep. Diana DeGette (D-CO), announced today that it will hold a hearing next week to hear directly from some of the nation’s leading scientists and public health experts about the criteria that makers of a COVID-19 vaccine should be required to meet before any potential cure is approved for distribution here in the U.S.

House passes short-term spending bill to avert government shutdown

September 22, 2020

Press Release

WASHINGTON, D.C. – The U.S. House of Representatives voted today to approve a short-term spending bill that will fund the federal government through December 11 and avert a government shutdown at the end of the month.

Pro-Choice Caucus leaders vow to continue Ginsburg’s legacy of fighting for women

September 19, 2020

Press Release

WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Barbara Lee (D-CA), the co-chairs of the Congressional Pro-Choice Caucus, released the following statement today as the group vows to carry on Supreme Court Justice Ruth Bader Ginsburg’s legacy of fighting for women’s rights:

Rep. Diana DeGette statement on the passing of Justice Ruth Bader Ginsburg

September 18, 2020

Press Release

WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) released the following statement on the passing of Supreme Court Justice Ruth Bader Ginsburg:

New reports bring into question Azar’s role in implementing Trump administration’s infamous family-separation policy

September 17, 2020

Press Release

WASHINGTON, D.C. – Newly published press reports have brought into question statements Health and Human Services Secretary Alex Azar made under oath in March 2019 when he told lawmakers he had no knowledge of the Trump administration’s plan to separate immigrant children from their families at the border before the policy was announced.

DeGette calls for investigation of alleged hysterectomies on immigrants

September 17, 2020

In The News

After a whistleblower complaint made public this week about alleged nonconsensual medical operations performed on detained immigrant women, Denver Democratic U.S. Rep. Diana DeGette is calling for the Department of Homeland Security’s inspector general to investigate.

The Gazette

U.S. lawmakers urge drug makers to take steps to increase public confidence in safety of COVID-19 vaccine

September 15, 2020

Press Release

WASHINGTON, D.C. – Three prominent U.S. lawmakers are calling on the heads of the nine pharmaceutical companies working to develop a coronavirus vaccine to provide more information about their research and development efforts and explain how they intend to ensure that only a safe and effective product is made available to the public.

Lawmakers call on Azar to take immediate action to protect nation’s safety-net hospitals

September 14, 2020

Press Release

WASHINGTON, D.C. —More than 240 members of the U.S. House of Representatives – led by U.S. Reps. Diana DeGette (D-CO) and David McKinley (R-WV) – sent a letter today to the head of the Dept. of Health and Human Services, Secretary Alex Azar, urging the agency to take immediate action to ensure drug makers continue to provide discounts to the nation’s safety-net hospitals as required under the 340B Drug Pricing Program.

Newsroom

Latest News